Structural insights into mitochondrial antiviral signaling protein (MAVS)-Tumor necrosis factor receptor-associated factor 6 (TRAF6) signaling

Journal of Biological Chemistry

Volumn 290, Issue 44, 2015, Pages 26811-26820

  Shi, Zhubing ^a,b   Zhang, Zhen ^b   Zhang, Zhenzhen ^b   Wang, Yanyan ^b   Li, Chuanchuan ^b   Wang, Xin ^b   He, Feng ^b   Sun, Lina ^c   Jiao, Shi ^b   Shi, Weiyang ^a   Zhou, Zhaocai ^b  

^a TONGJI UNIVERSITY   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^c QINGDAO BINHAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BINS;

ANTIVIRAL RESPONSE; SIGNALING PROTEINS; STRUCTURAL INSIGHTS; STRUCTURAL UNDERSTANDING; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED FACTORS;

SIGNALING;

MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN; MITOCHONDRIAL PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; TYROSINE; UNCLASSIFIED DRUG; HYBRID PROTEIN; LUCIFERASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; VISA PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; BINDING SITE; COMPLEX FORMATION; CRYSTAL STRUCTURE; EMBRYO; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; ESCHERICHIA COLI; FIBROBLAST; GENE EXPRESSION; GENETICS; HEK293 CELL LINE; HOST PATHOGEN INTERACTION; HUMAN; KNOCKOUT MOUSE; METABOLISM; MITOCHONDRION; MOLECULAR GENETICS; MUTATION; PHYSIOLOGY; PROTEIN DOMAIN; PROTEIN SECONDARY STRUCTURE; REPORTER GENE; SENDAI VIRUS; VIROLOGY; X RAY CRYSTALLOGRAPHY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANIMALS; CRYSTALLOGRAPHY, X-RAY; ESCHERICHIA COLI; FIBROBLASTS; GENE EXPRESSION; GENES, REPORTER; HEK293 CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; LUCIFERASES; MICE; MICE, KNOCKOUT; MITOCHONDRIA; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT FUSION PROTEINS; SENDAI VIRUS; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 84946038891     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.666578     Document Type: Article

References (50)

1. Loo, Y. M., and Gale, M. Jr. (2011) Immune signaling by RIG-I-like receptors. Immunity 34, 680-692.
2. Goubau, D., Deddouche, S., and Reis e Sousa, C. (2013) Cytosolic sensing of viruses. Immunity 38, 855-869.
3. Hornung, V., Ellegast, J., Kim, S., Brzózka, K., Jung, A., Kato, H., Poeck, H., Akira, S., Conzelmann, K. K., Schlee, M., Endres, S., and Hartmann, G. (2006) 5-TriphosphateRNAis the ligand for RIG-I. Science 314, 994-997.
4. Goubau, D., Schlee, M., Deddouche, S., Pruijssers, A. J., Zillinger, T., Goldeck, M., Schuberth, C., Van der Veen, A. G., Fujimura, T., Rehwinkel, J., Iskarpatyoti, J. A., Barchet, W., Ludwig, J., Dermody, T. S., Hartmann, G., and Reis e Sousa, C. (2014) Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5-diphosphates. Nature 514, 372-375.
5. Luo, D., Ding, S. C., Vela, A., Kohlway, A., Lindenbach, B. D., and Pyle, A. M. (2011) Structural insights into RNA recognition by RIG-I. Cell 147, 409-422.
6. Kowalinski, E., Lunardi, T., McCarthy, A. A., Louber, J., Brunel, J., Grigorov, B., Gerlier, D., and Cusack, S. (2011) Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 147, 423-435.
7. Jiang, F., Ramanathan, A., Miller, M. T., Tang, G. Q., Gale, M. Jr., Patel, S. S., and Marcotrigiano, J. (2011) Structural basis of RNA recognition and activation by innate immune receptor RIG-I. Nature 479, 423-427.
8. Gack, M. U., Shin, Y. C., Joo, C. H., Urano, T., Liang, C., Sun, L., Takeuchi, O., Akira, S., Chen, Z., Inoue, S., and Jung, J. U. (2007) TRIM25 RINGfinger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446, 916-920.
9. Zeng, W., Sun, L., Jiang, X., Chen, X., Hou, F., Adhikari, A., Xu, M., and Chen, Z. J. (2010) Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 141, 315-330.
10. Peisley, A., Wu, B., Yao, H., Walz, T., and Hur, S. (2013) RIG-I forms signaling-competent filaments in an ATP-dependent, ubiquitin-independent manner. Mol. Cell 51, 573-583.
11. Peisley, A., Wu, B., Xu, H., Chen, Z. J., and Hur, S. (2014) Structural basis for ubiquitin-mediated antiviral signal activation by RIG-I. Nature 509, 110-114.
12. Wu, B., Peisley, A., Richards, C., Yao, H., Zeng, X., Lin, C., Chu, F., Walz, T., and Hur, S. (2013) Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell 152, 276-289.
13. Satoh, T., Kato, H., Kumagai, Y., Yoneyama, M., Sato, S., Matsushita, K., Tsujimura, T., Fujita, T., Akira, S., and Takeuchi, O. (2010) LGP2 is a positive regulator of RIG-I- And MDA5-mediated antiviral responses. Proc. Natl. Acad. Sci. U.S.A. 107, 1512-1517.
14. Rothenfusser, S., Goutagny, N., DiPerna, G., Gong, M., Monks, B. G., Schoenemeyer, A., Yamamoto, M., Akira, S., and Fitzgerald, K. A. (2005) The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J. Immunol. 175, 5260-5268.
15. Bruns, A. M., Leser, G. P., Lamb, R. A., and Horvath, C. M. (2014) The innate immune sensor LGP2 activates antiviral signaling by regulating MDA5-RNA interaction and filament assembly. Mol. Cell 55, 771-781.
16. Seth, R. B., Sun, L., Ea, C. K., and Chen, Z. J. (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-B and IRF 3. Cell 122, 669-682.
17. Xu, L. G., Wang, Y. Y., Han, K. J., Li, L. Y., Zhai, Z., and Shu, H. B. (2005) VISA is an adapter protein required for virus-triggered IFN-β signaling. Mol. Cell 19, 727-740.
18. Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K. J., Takeuchi, O., and Akira, S. (2005) IPS-1, an adaptor triggering RIG-Iand Mda5-mediated type I interferon induction. Nat. Immunol. 6, 981-988.
19. Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R., and Tschopp, J. (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437, 1167-1172.
20. Xu, H., He, X., Zheng, H., Huang, L. J., Hou, F., Yu, Z., de la Cruz, M. J., Borkowski, B., Zhang, X., Chen, Z. J., and Jiang, Q. X. (2014) Structural basis for the prion-likeMAVSfilaments in antiviral innate immunity. Elife 3, e01489.
21. Wu, B., Peisley, A., Tetrault, D., Li, Z., Egelman, E. H., Magor, K. E., Walz, T., Penczek, P. A., and Hur, S. (2014) Molecular imprinting as a signalactivation mechanism of the viral RNA sensor RIG-I. Mol. Cell 55, 511-523.
22. Hou, F., Sun, L., Zheng, H., Skaug, B., Jiang, Q. X., and Chen, Z. J. (2011) MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 146, 448-461.
23. Saha, S. K., Pietras, E. M., He, J. Q., Kang, J. R., Liu, S. Y., Oganesyan, G., Shahangian, A., Zarnegar, B., Shiba, T. L., Wang, Y., and Cheng, G. (2006) Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J. 25, 3257-3263.
24. Guo, B., and Cheng, G. (2007) Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK. J. Biol. Chem. 282, 11817-11826.
25. Michallet, M. C., Meylan, E., Ermolaeva, M. A., Vazquez, J., Rebsamen, M., Curran, J., Poeck, H., Bscheider, M., Hartmann, G., König, M., Kalinke, U., Pasparakis, M., and Tschopp, J. (2008) TRADD protein is an essential component of the RIG-like helicase antiviral pathway. Immunity 28, 651-661.
26. Yoshida, R., Takaesu, G., Yoshida, H., Okamoto, F., Yoshioka, T., Choi, Y., Akira, S., Kawai, T., Yoshimura, A., and Kobayashi, T. (2008) TRAF6 and MEKK1 play a pivotal role in the RIG-I-like helicase antiviral pathway. J. Biol. Chem. 283, 36211-36220.
27. Liu, S., Chen, J., Cai, X., Wu, J., Chen, X., Wu, Y. T., Sun, L., and Chen, Z. J. (2013) MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades. Elife 2, e00785.
28. Wang, Y., Zhang, P., Liu, Y., and Cheng, G. (2010) TRAF-mediated regulation of immune and inflammatory responses. Sci. China Life Sci. 53, 159-168.
29. Xie, P. (2013) TRAF molecules in cell signaling and in human diseases. J. Mol. Signal. 8, 7.
30. Zhang, P., Reichardt, A., Liang, H., Aliyari, R., Cheng, D., Wang, Y., Xu, F., Cheng, G., and Liu, Y. (2012) Single amino acid substitutions confer the antiviral activity of the TRAF3 adaptor protein onto TRAF5. Sci. Signal. 5, ra81.
31. Wu, S., Xie, P., Welsh, K., Li, C., Ni, C. Z., Zhu, X., Reed, J. C., Satterthwait, A. C., Bishop, G. A., and Ely, K. R. (2005) LMP1 protein from the Epstein- Barr virus is a structural CD40 decoy in B lymphocytes for binding to TRAF3. J. Biol. Chem. 280, 33620-33626.
32. Ni, C. Z., Oganesyan, G., Welsh, K., Zhu, X., Reed, J. C., Satterthwait, A. C., Cheng, G., and Ely, K. R. (2004) Key molecular contacts promote recognition of the BAFF receptor by TNF receptor-associated factor 3: implications for intracellular signaling regulation. J. Immunol. 173, 7394 -7400.
33. Ye, H., Arron, J. R., Lamothe, B., Cirilli, M., Kobayashi, T., Shevde, N. K., Segal, D., Dzivenu, O. K., Vologodskaia, M., Yim, M., Du, K., Singh, S., Pike, J. W., Darnay, B. G., Choi, Y., and Wu, H. (2002) Distinct molecular mechanism for initiating TRAF6 signalling. Nature 418, 443-447.
34. Li, C., Ni, C. Z., Havert, M. L., Cabezas, E., He, J., Kaiser, D., Reed, J. C., Satterthwait, A. C., Cheng, G., and Ely, K. R. (2002) Downstream regulator TANK binds to the CD40 recognition site on TRAF3. Structure 10, 403-411.
35. Ni, C. Z., Welsh, K., Leo, E., Chiou, C. K., Wu, H., Reed, J. C., and Ely, K. R. (2000) Molecular basis for CD40 signaling mediated by TRAF3. Proc. Natl. Acad. Sci. U.S.A. 97, 10395-10399.
36. Ye, H., Park, Y. C., Kreishman, M., Kieff, E., and Wu, H. (1999) The structural basis for the recognition of diverse receptor sequences by TRAF2. Mol. Cell 4, 321-330.
37. Park, Y. C., Burkitt, V., Villa, A. R., Tong, L., and Wu, H. (1999) Structural basis for self-association and receptor recognition of human TRAF2. Nature 398, 533-538.
38. McWhirter, S. M., Pullen, S. S., Holton, J. M., Crute, J. J., Kehry, M. R., and Alber, T. (1999) Crystallographic analysis of CD40 recognition and signaling by human TRAF2. Proc. Natl. Acad. Sci. U.S.A. 96, 8408-8413.
39. Häcker, H., Tseng, P. H., and Karin, M. (2011) Expanding TRAF function: TRAF3 as a tri-faced immune regulator. Nat. Rev. Immunol. 11, 457-468.
40. Shi, Z., Jiao, S., Zhang, Z., Ma, M., Zhang, Z., Chen, C., Wang, K., Wang, H., Wang, W., Zhang, L., Zhao, Y., and Zhou, Z. (2013) Structure of the MST4 in complex with MO25 provides insights into its activation mechanism. Structure 21, 449-461.
41. Otwinowski, Z., and Minor, W. (1997) Processing of x-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326.
42. Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L. W., Kapral, G. J., Grosse-Kunstleve, R. W., Mc-Coy, A. J., Moriarty, N. W., Oeffner, R., Read, R. J., Richardson, D. C., Richardson, J. S., Terwilliger, T. C., and Zwart, P. H. (2010) PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213-221.
43. McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., and Read, R. J. (2007) Phaser crystallographic software. J. Appl. Crystallogr. 40, 658-674.
44. Emsley, P., Lohkamp, B., Scott, W. G., and Cowtan, K. (2010) Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486-501.
45. Afonine, P. V., Grosse-Kunstleve, R. W., Echols, N., Headd, J. J., Moriarty, N. W., Mustyakimov, M., Terwilliger, T. C., Urzhumtsev, A., Zwart, P. H., and Adams, P. D. (2012) Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr. D Biol. Crystallogr. 68, 352-367.
46. Vitour, D., Dabo, S., Ahmadi Pour, M., Vilasco, M., Vidalain, P. O., Jacob, Y., Mezel-Lemoine, M., Paz, S., Arguello, M., Lin, R., Tangy, F., Hiscott, J., and Meurs, E. F. (2009) Polo-like kinase 1 (PLK1) regulates interferon(IFN) induction by MAVS. J. Biol. Chem. 284, 21797-21809.
47. Paz, S., Vilasco, M., Werden, S. J., Arguello, M., Joseph-Pillai, D., Zhao, T., Nguyen, T. L., Sun, Q., Meurs, E. F., Lin, R., and Hiscott, J. (2011) A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral response. Cell Res. 21, 895-910.
48. Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P. A., McWilliam, H., Valentin, F., Wallace, I. M., Wilm, A., Lopez, R., Thompson, J. D., Gibson, T. J., and Higgins, D. G. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23, 2947-2948.
49. Gouet, P., Robert, X., and Courcelle, E. (2003) ESPript/ENDscript: Extracting and rendering sequence and 3D information from atomic structures of proteins. Nucleic Acids Res. 31, 3320-3323.
50. Gouet, P., Courcelle, E., Stuart, D. I., and Métoz, F. (1999) ESPript: Analysis of multiple sequence alignments in PostScript. Bioinformatics 15, 305-308.